Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.
暂无分享,去创建一个
Robert Turner | Andreas Schäfer | Pierre-Louis Bazin | Marianne Patt | Osama Sabri | Solveig Tiepolt | Henryk Barthel | Matthias L Schroeter | Elisabeth Roggenhofer | Michael Rullmann | Hermann-Josef Gertz | Thies H Jochimsen | R. Turner | P. Bazin | M. Schroeter | T. Jochimsen | A. Schäfer | H. Gertz | S. Tiepolt | M. Patt | O. Sabri | H. Barthel | E. Roggenhofer | M. Rullmann
[1] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[2] Tobias Kober,et al. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field , 2010, NeuroImage.
[3] C. Rowe,et al. Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[4] Dan Wang,et al. Age-related iron deposition in the basal ganglia of controls and Alzheimer disease patients quantified using susceptibility weighted imaging. , 2014, Archives of gerontology and geriatrics.
[5] Yukihiko Fujii,et al. In Vivo Visualization of Senile‐Plaque‐Like Pathology in Alzheimer's Disease Patients by MR Microscopy on a 7T System , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[6] E. Haacke,et al. Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. , 2009, Journal of Alzheimer's disease : JAD.
[7] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[8] Mark A. Smith,et al. Iron, zinc and copper in the Alzheimer's disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion , 2011, Progress in Neurobiology.
[9] G. Perry,et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[10] John Seibyl,et al. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study , 2011, The Lancet Neurology.
[11] D. Leys,et al. Iron deposits in post‐mortem brains of patients with neurodegenerative and cerebrovascular diseases: a semi‐quantitative 7.0 T magnetic resonance imaging study , 2014, European journal of neurology.
[12] Agostinho Santos,et al. ioinorganic chemistry ron levels in the human brain : A post-mortem study of anatomical egion differences and age-related changes , 2013 .
[13] Hua-wei Ling,et al. Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease , 2009, Journal of magnetic resonance imaging : JMRI.
[14] Jon Dobson,et al. High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: Quantitative imaging and correlation with iron , 2012, NeuroImage.
[15] Frederik Barkhof,et al. Whole brain analysis of T2* weighted baseline FMRI signal in dementia , 2007, Human brain mapping.
[16] Ferdinand Schweser,et al. Toward online reconstruction of quantitative susceptibility maps: Superfast dipole inversion , 2013, Magnetic resonance in medicine.
[17] Yi Wang,et al. Calculation of susceptibility through multiple orientation sampling (COSMOS): A method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI , 2009, Magnetic resonance in medicine.
[18] G. Bartzokis,et al. In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. , 2000, Archives of general psychiatry.
[19] Christian Langkammer,et al. MRI for Iron Mapping in Alzheimer's Disease , 2013, Neurodegenerative Diseases.
[20] Dzung L. Pham,et al. Spatial Models for Fuzzy Clustering , 2001, Comput. Vis. Image Underst..
[21] H. Gertz,et al. Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[22] Juliane Dinse,et al. A computational framework for ultra-high resolution cortical segmentation at 7Tesla , 2014, NeuroImage.
[23] Eveliina Arponen,et al. Visual assessment of [11C]PIB PET in patients with cognitive impairment , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[24] Guy B. Williams,et al. In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease , 2013, PloS one.
[25] C. Masters,et al. Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease , 2010, Cell.
[26] Jean-Francois Mangin,et al. R2* mapping for brain iron: associations with cognition in normal aging , 2015, Neurobiology of Aging.
[27] Wei Wang,et al. Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2′ mapping , 2011, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[28] John Seibyl,et al. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study , 2015, Alzheimer's & Dementia.
[29] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[30] B. Rutt,et al. Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease , 2015, Neurobiology of Aging.
[31] Brian B. Avants,et al. Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..
[32] Swen Hesse,et al. Influence of scan duration on the accuracy of β-amyloid PET with florbetaben in patients with Alzheimer’s disease and healthy volunteers , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[33] Xiaojun Xu,et al. Age, gender, and hemispheric differences in iron deposition in the human brain: An in vivo MRI study , 2008, NeuroImage.
[34] Torsten Rohlfing,et al. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping , 2011, NeuroImage.
[35] Jouke Dijkstra,et al. Postmortem MRI and histology demonstrate differential iron accumulation and cortical myelin organization in early- and late-onset Alzheimer's disease , 2018, Neurobiology of Aging.
[36] M. Esiri,et al. Brain burdens of aluminum, iron, and copper and their relationships with amyloid-β pathology in 60 human brains. , 2012, Journal of Alzheimer's disease : JAD.
[37] A. F. Gietl,et al. Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment , 2016, Scientific Reports.